Adiponectin-resistin index and its strong association with acute coronary syndrome in South Indian men

Inflammation Research

Volumn 63, Issue 11, 2014, Pages 961-968

  Singh, Prerna ^a   Sridhar, M G ^a   Rajappa, Medha ^a   Balachander, J ^a   Kadhiravan, Tamilarasu ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acute coronary syndrome; Adipokines; Insulin resistance

Indexed keywords

ADIPONECTIN; INSULIN; INTERLEUKIN 6; RESISTIN; GLUCOSE BLOOD LEVEL; IL6 PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; INDIA; INDIAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; ANALYSIS; BLOOD; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL;

ACUTE CORONARY SYNDROME; ADIPONECTIN; ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; HUMANS; INDIA; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MIDDLE AGED; RESISTIN;

EID: 84919952039     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-014-0771-z     Document Type: Article

References (24)

1. Pischon T, Rimm EB. Adiponectin and risk of acute coronary syndromes: defining the obesity phenotype. Eur Heart J. 2007;28:274–5.
2. Gupta R, Joshi P, Mohan V, et al. Epidemiology and causation of coronary heart disease and stroke in India. Heart. 2008;94:16–26.
3. Gupta Rajeev. Burden of coronary heart disease in India. Indian Heart J. 2005;57:632–8.
4. Wolk R, Berger P, Lennon RJ, Brilakis ES, Davison DE, Somers VK. Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J. 2007;28:292–8.
5. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85–9.
6. Qiao X, Yang Y, Xu Z, Yang L. Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris. J Zhejiang Univ Sci B. 2007;8:875–80.
7. Chu S, Ding W, Li K, Pang Y, Tang C. Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circ J. 2008;72:1249–53.
8. Alwi I, Santoso T, Suyono S, Sutrisna B, Kresno SB. The cut-off point of interleukin-6 level in acute coronary syndrome. Indones J Intern Med. 2007;39:174–8.
9. Ramachandran A, Chamukuttan S, Immaneni S, Shanmugam RM, Vishnu N, Viswanathan V, Jaakko T. High incidence of glucose intolerance in Asian-Indian subjects with acute coronary syndrome. Diabetes Care. 2005;28:2492–5.
10. Stubbs PJ, Alaghband-Zadeh J, Laycock JF, Collinson PO, Carter GD, Noble MIM. Significance of an index of insulin resistance on admission in non-diabetic patients with acute coronary syndromes. Heart. 1999;82:443–7.
11. Stubbs PJ, Laycock JF, Alaghband-Zadeh J, Carter GD, Noble MIM. Circulating stress hormone and insulin concentrations in acute coronary syndromes: identification of insulin resistance on admission. Clin Sci (Lond). 1999;96:595–6.
12. AR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study. Cardiovasc Diabetol. 2011;10:1–18.
13. Killip T. III, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457–64.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
15. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 2004;90:528–33.
16. Krecki R, Krzeminska-Pakula M, Peruga JZ, Szczesniak P, Lipiec P, Wierzbowska-Drabik K, et al. Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multi vessel coronary artery disease over 1-year follow-up. Med Sci Monit. 2011;17:CR26–32.
17. Wasim H, Al-Daghri NM, Chetty R, McTernan PG, Barnett AH, Kumar S. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol. 2006;5:1–5.
18. Lewandowski KC, Szosland K, O’Callaghan C, Tan BK, Randeva HS, Lewinski A. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Mol Genet Metab. 2005;85:61–9.
19. Burnett MS, Lee CW, Kinnaird TD, et al. The potential role of resistin in atherogenesis. Atherosclerosis. 2005;182:241–8.
20. Tan J, Hua Q. Correlations between serum inflammation factors and left ventricular remodeling in acute ST segment elevation myocardial infarction. Yonsei Med J. 2012;53:501–7.
21. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932–9.
22. Rubio-Guerra AF, Cabrera-Miranda LJ, Vargas-Robles H, Maceda-Serrano A, Lozano-Nuevo JJ, Escalante-Acosta BA. Correlation between levels of circulating adipokines and adiponectin/resistin index with carotid intima-media thickness in hypertensive type 2 diabetic patients. Cardiology. 2013;125:150–3.
23. Hameed IK, Rashid NF, Abed BA. Homestasis Model Assessment-Adiponectin ratio and Adiponectin-Resistin index as markers of insulin resistance in type 2 diabetes mellitus. J Fac Med Baghdad. 2013;55:175–8.
24. Chavarria-Ávila E, Ruíz Quezada SL, Guzmán-Ornelas MO, Castro-Albarrán J, Aguilar Aldrete ME, Vásquez-Del Mercado M, et al. Association of resistin gene 3′UTR + 62G > A polymorphism with insulin resistance, adiposity and the adiponectin-resistin index in mexican population. Nutr Hosp. 2013;28:1867–76.